Selected research
Industry Research
Gene Expression Screening Service Industry Research Report 2026
Market perspective
The global Gene Expression Screening Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Gene Expression Screening Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Gene Expression Screening Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Gene Expression Screening Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Gene Expression Screening Service include EKF Diagnostics, Perkin Elmer, IntegraGen, Quest Diagnostics, Abbott Laboratories, Roche Diagnostics, Biocartis, Elitech Group and Interpace Diagnostics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Gene Expression Screening Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Gene Expression Screening Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gene Expression Screening Service Market by Company
EKF Diagnostics
Perkin Elmer
IntegraGen
Quest Diagnostics
Abbott Laboratories
Roche Diagnostics
Biocartis
Elitech Group
Interpace Diagnostics
Qiagen
AutoGenomics
Bio-Rad Laboratories
Cepheid
Gene Expression Screening Service Segment by Type
High-Throughput Screening
Low-Throughput Screening
Gene Expression Screening Service Segment by Application
Pharmaceutical Industry
Agricultural Industry
Environmental Science
Others
Gene Expression Screening Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Expression Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Expression Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Expression Screening Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Gene Expression Screening Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- High-Throughput Screening
- Low-Throughput Screening
Applications
- Pharmaceutical Industry
- Agricultural Industry
- Environmental Science
- Others
Companies covered
- EKF Diagnostics
- Perkin Elmer
- IntegraGen
- Quest Diagnostics
- Abbott Laboratories
- Roche Diagnostics
- Biocartis
- Elitech Group
- Interpace Diagnostics
- Qiagen
- AutoGenomics
- Bio-Rad Laboratories
- Cepheid
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Gene Expression Screening Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 High-Throughput Screening
- 2.2.3 Low-Throughput Screening
- 2.3 Gene Expression Screening Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Industry
- 2.3.3 Agricultural Industry
- 2.3.4 Environmental Science
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Gene Expression Screening Service Breakdown Data by Type
- 3.1 Global Gene Expression Screening Service Historic Market Size by Type (2021-2026)
- 3.2 Global Gene Expression Screening Service Forecasted Market Size by Type (2027-2032)
4 Gene Expression Screening Service Breakdown Data by Application
- 4.1 Global Gene Expression Screening Service Historic Market Size by Application (2021-2026)
- 4.2 Global Gene Expression Screening Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Gene Expression Screening Service Market Perspective (2021-2032)
- 5.2 Global Gene Expression Screening Service Growth Trends by Region
- 5.2.1 Global Gene Expression Screening Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Gene Expression Screening Service Historic Market Size by Region (2021-2026)
- 5.2.3 Gene Expression Screening Service Forecasted Market Size by Region (2027-2032)
- 5.3 Gene Expression Screening Service Market Dynamics
- 5.3.1 Gene Expression Screening Service Industry Trends
- 5.3.2 Gene Expression Screening Service Market Drivers
- 5.3.3 Gene Expression Screening Service Market Challenges
- 5.3.4 Gene Expression Screening Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Gene Expression Screening Service Players by Revenue
- 6.1.1 Global Top Gene Expression Screening Service Players by Revenue (2021-2026)
- 6.1.2 Global Gene Expression Screening Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Gene Expression Screening Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Gene Expression Screening Service Head Office and Area Served
- 6.4 Global Gene Expression Screening Service Players, Product Type & Application
- 6.5 Global Gene Expression Screening Service Manufacturers Established Date
- 6.6 Global Gene Expression Screening Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Gene Expression Screening Service Market Size (2021-2032)
- 7.2 North America Gene Expression Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Gene Expression Screening Service Market Size by Country (2021-2026)
- 7.4 North America Gene Expression Screening Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Gene Expression Screening Service Market Size (2021-2032)
- 8.2 Europe Gene Expression Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Gene Expression Screening Service Market Size by Country (2021-2026)
- 8.4 Europe Gene Expression Screening Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Gene Expression Screening Service Market Size (2021-2032)
- 9.2 Asia-Pacific Gene Expression Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Gene Expression Screening Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Gene Expression Screening Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Gene Expression Screening Service Market Size (2021-2032)
- 10.2 South America Gene Expression Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Gene Expression Screening Service Market Size by Country (2021-2026)
- 10.4 South America Gene Expression Screening Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Gene Expression Screening Service Market Size (2021-2032)
- 11.2 Middle East & Africa Gene Expression Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Gene Expression Screening Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Gene Expression Screening Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 EKF Diagnostics
- 12.1.1 EKF Diagnostics Company Information
- 12.1.2 EKF Diagnostics Business Overview
- 12.1.3 EKF Diagnostics Revenue in Gene Expression Screening Service Business (2021-2026)
- 12.1.4 EKF Diagnostics Gene Expression Screening Service Product Portfolio
- 12.1.5 EKF Diagnostics Recent Developments
- 12.2 Perkin Elmer
- 12.2.1 Perkin Elmer Company Information
- 12.2.2 Perkin Elmer Business Overview
- 12.2.3 Perkin Elmer Revenue in Gene Expression Screening Service Business (2021-2026)
- 12.2.4 Perkin Elmer Gene Expression Screening Service Product Portfolio
- 12.2.5 Perkin Elmer Recent Developments
- 12.3 IntegraGen
- 12.3.1 IntegraGen Company Information
- 12.3.2 IntegraGen Business Overview
- 12.3.3 IntegraGen Revenue in Gene Expression Screening Service Business (2021-2026)
- 12.3.4 IntegraGen Gene Expression Screening Service Product Portfolio
- 12.3.5 IntegraGen Recent Developments
- 12.4 Quest Diagnostics
- 12.4.1 Quest Diagnostics Company Information
- 12.4.2 Quest Diagnostics Business Overview
- 12.4.3 Quest Diagnostics Revenue in Gene Expression Screening Service Business (2021-2026)
- 12.4.4 Quest Diagnostics Gene Expression Screening Service Product Portfolio
- 12.4.5 Quest Diagnostics Recent Developments
- 12.5 Abbott Laboratories
- 12.5.1 Abbott Laboratories Company Information
- 12.5.2 Abbott Laboratories Business Overview
- 12.5.3 Abbott Laboratories Revenue in Gene Expression Screening Service Business (2021-2026)
- 12.5.4 Abbott Laboratories Gene Expression Screening Service Product Portfolio
- 12.5.5 Abbott Laboratories Recent Developments
- 12.6 Roche Diagnostics
- 12.6.1 Roche Diagnostics Company Information
- 12.6.2 Roche Diagnostics Business Overview
- 12.6.3 Roche Diagnostics Revenue in Gene Expression Screening Service Business (2021-2026)
- 12.6.4 Roche Diagnostics Gene Expression Screening Service Product Portfolio
- 12.6.5 Roche Diagnostics Recent Developments
- 12.7 Biocartis
- 12.7.1 Biocartis Company Information
- 12.7.2 Biocartis Business Overview
- 12.7.3 Biocartis Revenue in Gene Expression Screening Service Business (2021-2026)
- 12.7.4 Biocartis Gene Expression Screening Service Product Portfolio
- 12.7.5 Biocartis Recent Developments
- 12.8 Elitech Group
- 12.8.1 Elitech Group Company Information
- 12.8.2 Elitech Group Business Overview
- 12.8.3 Elitech Group Revenue in Gene Expression Screening Service Business (2021-2026)
- 12.8.4 Elitech Group Gene Expression Screening Service Product Portfolio
- 12.8.5 Elitech Group Recent Developments
- 12.9 Interpace Diagnostics
- 12.9.1 Interpace Diagnostics Company Information
- 12.9.2 Interpace Diagnostics Business Overview
- 12.9.3 Interpace Diagnostics Revenue in Gene Expression Screening Service Business (2021-2026)
- 12.9.4 Interpace Diagnostics Gene Expression Screening Service Product Portfolio
- 12.9.5 Interpace Diagnostics Recent Developments
- 12.10 Qiagen
- 12.10.1 Qiagen Company Information
- 12.10.2 Qiagen Business Overview
- 12.10.3 Qiagen Revenue in Gene Expression Screening Service Business (2021-2026)
- 12.10.4 Qiagen Gene Expression Screening Service Product Portfolio
- 12.10.5 Qiagen Recent Developments
- 12.11 AutoGenomics
- 12.11.1 AutoGenomics Company Information
- 12.11.2 AutoGenomics Business Overview
- 12.11.3 AutoGenomics Revenue in Gene Expression Screening Service Business (2021-2026)
- 12.11.4 AutoGenomics Gene Expression Screening Service Product Portfolio
- 12.11.5 AutoGenomics Recent Developments
- 12.12 Bio-Rad Laboratories
- 12.12.1 Bio-Rad Laboratories Company Information
- 12.12.2 Bio-Rad Laboratories Business Overview
- 12.12.3 Bio-Rad Laboratories Revenue in Gene Expression Screening Service Business (2021-2026)
- 12.12.4 Bio-Rad Laboratories Gene Expression Screening Service Product Portfolio
- 12.12.5 Bio-Rad Laboratories Recent Developments
- 12.13 Cepheid
- 12.13.1 Cepheid Company Information
- 12.13.2 Cepheid Business Overview
- 12.13.3 Cepheid Revenue in Gene Expression Screening Service Business (2021-2026)
- 12.13.4 Cepheid Gene Expression Screening Service Product Portfolio
- 12.13.5 Cepheid Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst